US Patent Issued to Roche Diabetes Care on Feb. 25 for "Method of determining a concentration of an analyte in a bodily fluid" (German Inventors)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,235,219, issued on Feb. 25, was assigned to Roche Diabetes Care Inc. (Indianapolis).

"Method of determining a concentration of an analyte in a bodily fluid" was invented by Bernhard Limburg (Soergenloch, Germany), Max Berg (Mannheim, Germany), Fredrik Hailer (Limburgerhof, Germany), Volker Tuerck (Berlin), Daria Skuridina (Berlin) and Irina Ostapenko (Berlin).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of determining analyte concentration in a body fluid with a mobile device having a camera. A user is prompted to apply body fluid to an optical test strip and then waits a predetermined minimum waiting time. The camera captures an image of part...